AstraZeneca, Pfizer Apply For Emergency Use Authorizations Of Coronavirus Vaccines In India

Wall Street Journal: AstraZeneca and Pfizer Ask India for Emergency-Use Covid-19 Vaccine Authorizations
“The companies behind two of the most promising Covid-19 vaccine candidates, AstraZeneca PLC and Pfizer Inc., have asked India for emergency-use authorization to start using their vaccines in the South Asian nation, which has been one of the worst hit by the pandemic. Both Pfizer and Serum Institute of India — which is manufacturing AstraZeneca’s vaccine for developing countries — have applied for the authorization, which would allow their vaccines to circumvent a long trial and application process, said an official at the Drugs Controller General of India…” (Bellman, 12/7).

Additional coverage of the applications is available from Axios and Reuters.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.